News Focus
News Focus
icon url

dennisdave

04/01/25 5:43 PM

#758298 RE: DrHigh #758296

even MIT grad students are able to get $50 million on lab ideas from Merck (true story). If Powerless has not arranged a penny non dilutive cash she is even more inept than I thought. As I said I heard they have arranged a large sum, the specifics of that sum are unknown to me.

Raising the A/S to 3 billion or R/S doesn't mean that all of a sudden the monthly hand-to-mouth financing of $500 million (my estimate for their insane plans) will be over, even with MHRA approval. If they intend to keep diluting after UK approval the share price will not go anywhere
icon url

Investor082

04/01/25 5:54 PM

#758304 RE: DrHigh #758296

Agreed. Thats exactly what will happen. Hopefully the UK approval happens sooner so we can at least get 30 cents or thereabouts. Big pharma is not interested in NWBO and its IP. Neither were they interested in Roswell Park’s IP. No wonder Roswell Park had to offload it to NWBO for a couple million upfront payment given the lack of interest in DC based technology as opposed to what they did with SurvaXM.